Both ACE and HSPB8 showed significant negative correlations with mRNAsi, indicating involvement in tumor cell differentiation, growth rate, and invasiveness modulation, underscoring their potential as therapeutic targets in LUSC. The gene discussed is HSPB8; the disease is neoplasm.